2,238,147 Shares in Alignment Healthcare, Inc. $ALHC Bought by Capital World Investors

Capital World Investors acquired a new position in shares of Alignment Healthcare, Inc. (NASDAQ:ALHC) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 2,238,147 shares of the company’s stock, valued at approximately $44,203,000.

Other large investors have also modified their holdings of the company. Parallel Advisors LLC boosted its holdings in shares of Alignment Healthcare by 87.7% during the 4th quarter. Parallel Advisors LLC now owns 1,654 shares of the company’s stock worth $33,000 after buying an additional 773 shares during the period. Larson Financial Group LLC bought a new stake in shares of Alignment Healthcare during the 3rd quarter worth $33,000. First Horizon Corp bought a new stake in shares of Alignment Healthcare during the 4th quarter worth $39,000. GAMMA Investing LLC boosted its holdings in shares of Alignment Healthcare by 83.8% during the 4th quarter. GAMMA Investing LLC now owns 2,165 shares of the company’s stock worth $43,000 after buying an additional 987 shares during the period. Finally, Wilmington Savings Fund Society FSB bought a new stake in shares of Alignment Healthcare during the 3rd quarter worth $53,000. 86.19% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of analysts have weighed in on ALHC shares. Wolfe Research started coverage on shares of Alignment Healthcare in a report on Friday, April 17th. They issued an “outperform” rating and a $24.00 price target for the company. Zacks Research raised shares of Alignment Healthcare from a “hold” rating to a “strong-buy” rating in a report on Tuesday, April 28th. Wall Street Zen raised shares of Alignment Healthcare from a “hold” rating to a “buy” rating in a report on Saturday, May 9th. Barclays reduced their price target on shares of Alignment Healthcare from $19.00 to $16.00 and set an “equal weight” rating for the company in a report on Tuesday, May 26th. Finally, Raymond James Financial set a $22.00 price target on shares of Alignment Healthcare in a report on Thursday, May 7th. One research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $24.30.

Alignment Healthcare Price Performance

Shares of Alignment Healthcare stock opened at $19.20 on Wednesday. The company has a debt-to-equity ratio of 1.56, a current ratio of 1.58 and a quick ratio of 1.58. Alignment Healthcare, Inc. has a fifty-two week low of $11.63 and a fifty-two week high of $23.87. The firm has a fifty day moving average price of $18.36 and a two-hundred day moving average price of $19.34. The company has a market cap of $3.97 billion, a PE ratio of 213.33, a price-to-earnings-growth ratio of 2.07 and a beta of 1.14.

Alignment Healthcare (NASDAQ:ALHC) last issued its quarterly earnings results on Thursday, April 30th. The company reported $0.05 earnings per share for the quarter, beating analysts’ consensus estimates of $0.01 by $0.04. Alignment Healthcare had a net margin of 0.47% and a return on equity of 11.50%. The firm had revenue of $1.24 billion during the quarter, compared to the consensus estimate of $1.22 billion. During the same period in the prior year, the firm earned ($0.05) EPS. The business’s revenue was up 33.3% on a year-over-year basis. Analysts expect that Alignment Healthcare, Inc. will post 0.2 EPS for the current year.

Insiders Place Their Bets

In other news, CEO John E. Kao sold 298,000 shares of the stock in a transaction on Monday, May 11th. The shares were sold at an average price of $16.89, for a total value of $5,033,220.00. Following the completion of the transaction, the chief executive officer owned 1,508,641 shares in the company, valued at approximately $25,480,946.49. This represents a 16.49% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, President Dawn Christine Maroney sold 36,749 shares of the stock in a transaction on Wednesday, March 18th. The shares were sold at an average price of $17.84, for a total transaction of $655,602.16. Following the completion of the transaction, the president owned 1,058,813 shares of the company’s stock, valued at approximately $18,889,223.92. This represents a 3.35% decrease in their position. The SEC filing for this sale provides additional information. In the last 90 days, insiders sold 1,368,741 shares of company stock valued at $25,765,741. Corporate insiders own 5.20% of the company’s stock.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.